{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:36:10Z","timestamp":1787063770739,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jpsychires.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T17:31:00Z","timestamp":1536082260000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells"],"prefix":"10.1016","volume":"105","author":[{"given":"Britta","family":"Stapel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Sieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-7318","authenticated-orcid":false,"given":"Christine S.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Hilfiker-Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai G.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","article-title":"Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures","volume":"11","author":"Al-Amin","year":"2013","journal-title":"Clin. Psychopharmacol. Neurosci.: Offic. Sci. J. Kor. Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/08039488.2015.1074285","article-title":"Treatment of adult patients with schizophrenia and complex mental health needs - a national clinical guideline","volume":"70","author":"Baandrup","year":"2016","journal-title":"Nord. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.08.017_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0278-5846(03)00036-8","article-title":"The influence of olanzapine on immune cells in patients with schizophrenia","volume":"27","author":"Bilici","year":"2003","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.immuni.2016.04.005","article-title":"Brain endothelial- and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment","volume":"44","author":"Blank","year":"2016","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jpsychires.2018.08.017_bib7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","article-title":"Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse","volume":"46","author":"Borovcanin","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","article-title":"Acute variations of cytokine levels after antipsychotic treatment in drug-naive subjects with a first-episode psychosis: a meta-analysis","volume":"77","author":"Capuzzi","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000369978","article-title":"Second-generation antipsychotic drugs in anorexia nervosa: a meta-analysis of randomized controlled trials","volume":"84","author":"Dold","year":"2015","journal-title":"Psychother. Psychosom."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.08.017_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","article-title":"The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction","volume":"31","author":"Engelhardt","year":"2009","journal-title":"Semin. Immunopathol."},{"issue":"19","key":"10.1016\/j.jpsychires.2018.08.017_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection","year":"2001","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib14","first-page":"135","article-title":"Interleukin-17 alteration in first-episode psychosis: a meta-analysis","volume":"3","author":"Fang","year":"2018","journal-title":"Mol. Neuropsychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1753425915613425","article-title":"Effects of olanzapine on LPS-induced inflammation in rat primary glia cells","volume":"22","author":"Faour-Nmarne","year":"2016","journal-title":"Innate Immun."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jlb.61.3.246","article-title":"Mig and IP-10: CXC chemokines that target lymphocytes","volume":"61","author":"Farber","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","article-title":"Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations","volume":"31","author":"Felger","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mp.2015.87","article-title":"C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications","volume":"21","author":"Fernandes","year":"2016","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2018.08.017_bib19","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib20","first-page":"1","article-title":"Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications","volume":"2","author":"Fonseka","year":"2016","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.jpsychires.2018.08.017_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","article-title":"Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study","volume":"71","author":"Frydecka","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib22","doi-asserted-by":"crossref","first-page":"e90407","DOI":"10.1371\/journal.pone.0090407","article-title":"Association of interleukin-10 polymorphisms with schizophrenia: a meta-analysis","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2018.08.017_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2016.03.039","article-title":"Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers","volume":"174","author":"Handley","year":"2016","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.08.017_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","article-title":"Depression, comorbidities and the TNF-alpha system","volume":"23","author":"Himmerich","year":"2008","journal-title":"Eur. Psychiatr. : J. Assoc. Eur. Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2018.08.017_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","article-title":"Impact of antipsychotics on cytokine production in-vitro","volume":"45","author":"Himmerich","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2016.09.019","article-title":"Abnormalities in chemokine levels in schizophrenia and their clinical correlates","volume":"181","author":"Hong","year":"2017","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/28.1.86-b","article-title":"Rheumatoid arthritis and senile dementia of the Alzheimer's type","volume":"28","author":"Jenkinson","year":"1989","journal-title":"Br. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0306-4530(02)00131-2","article-title":"Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa","volume":"29","author":"Kahl","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1471-4159.2008.05435.x","article-title":"Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro","volume":"106","author":"Kato","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib31","series-title":"The Impact of Food Bioactives on Health","article-title":"Peripheral blood mononuclear cells","author":"Kleiveland","year":"2015"},{"issue":"7","key":"10.1016\/j.jpsychires.2018.08.017_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"Kohler","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"2 Suppl. l","key":"10.1016\/j.jpsychires.2018.08.017_bib33","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","article-title":"Serum chemokine levels in major depressive disorder","volume":"35","author":"Lehto","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.08.017_bib36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress. Anxiety"},{"issue":"7","key":"10.1016\/j.jpsychires.2018.08.017_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib39","first-page":"187","article-title":"The case for adjunctive monoclonal antibody immunotherapy in schizophrenia","volume":"39","author":"Miller","year":"2016","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/289645","article-title":"Chronic inflammation in obesity and the metabolic syndrome","author":"Monteiro","year":"2010","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.31887\/DCNS.2017.19.1\/nmueller","article-title":"Immunological aspects of the treatment of depression and schizophrenia","volume":"19","author":"Muller","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.08.017_bib42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"Muller","year":"2002","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00406-004-0548-4","article-title":"Clinical effects of COX-2 inhibitors on cognition in schizophrenia","volume":"255","author":"Muller","year":"2005","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.08.017_bib44","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.08.017_bib45","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.08.017_bib46","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/138920008785821738","article-title":"Chronic immune stimulation correlates with reduced phenylalanine turnover","volume":"9","author":"Neurauter","year":"2008","journal-title":"Curr. Drug Metabol."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.08.017_bib47","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.08.017_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3956(00)00032-7","article-title":"Effects of antipsychotic drugs on cytokine networks","volume":"34","author":"Pollmacher","year":"2000","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.08.017_bib49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/YCO.0b013e32833f46c9","article-title":"Cardiovascular aspects of antipsychotics","volume":"23","author":"Raedler","year":"2010","journal-title":"Curr. Opin. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.08.017_bib51","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib52","first-page":"903796","article-title":"Cognitive status correlates with CXCL10\/IP-10 levels in Parkinson's disease","volume":"2014","author":"Rocha","year":"2014","journal-title":"Parkinson's Dis."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.08.017_bib53","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.137.12.3841","article-title":"The released interleukin 2 receptor binds interleukin 2 efficiently","volume":"137","author":"Rubin","year":"1986","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.08.017_bib54","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.08.017_bib55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.pmrj.2009.10.004","article-title":"The problem of multiple testing","volume":"1","author":"Sainani","year":"2009","journal-title":"PM & R : J. Inj. Funct. Rehabil."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.autrev.2011.09.005","article-title":"Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly","volume":"11","author":"Sardi","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.017_bib57","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"Sarvari","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.psychres.2016.02.052","article-title":"Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression","volume":"239","author":"Schmidt","year":"2016","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.psyneuen.2014.09.031","article-title":"Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross-sectional and longitudinal studies","volume":"51","author":"Solmi","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.08.017_bib60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","article-title":"The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia","volume":"65","author":"Song","year":"2009","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.017_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/ijms.13800","article-title":"Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west virginian population","volume":"13","author":"Srikanthan","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2016.12.012","article-title":"Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells","volume":"88","author":"Stapel","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2015.10.010","article-title":"Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats","volume":"81","author":"Todorovic","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci. : Offic. J. Eur. Fed. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"Tsuchiya","year":"1980","journal-title":"Int. J. Canc."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.017_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0269881113507640","article-title":"A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: a European perspective","volume":"28","author":"Turner","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.08.017_bib66","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/mp.2008.59","article-title":"Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response","volume":"13","author":"Wong","year":"2008","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.017_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2017.12.006","article-title":"Syk and Src-targeted anti-inflammatory activity of aripiprazole, an atypical antipsychotic","volume":"148","author":"Yoo","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.08.017_bib68","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0269881114555250","article-title":"Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female rats","volume":"28","author":"Zhang","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.jpsychires.2018.08.017_bib69","doi-asserted-by":"crossref","first-page":"pyv060","DOI":"10.1093\/ijnp\/pyv060","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"13","key":"10.1016\/j.jpsychires.2018.08.017_bib70","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters","volume":"35","author":"Zhu","year":"2010","journal-title":"Neuropsychopharmacology : Offic. Publ. Am. Coll. Neuropsychopharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618305363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618305363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:12:13Z","timestamp":1758366733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618305363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":70,"alternative-id":["S0022395618305363"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.08.017","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}